Trial record 1 of 1 for:    EoE and Novartis
Previous Study | Return to List | Next Study

Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: November 25, 2009
Last updated: November 21, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: October 29, 2013